Secondary analysis at 15 years of the SWOG S0016 trial in 531 patients with advanced follicular lymphoma: OS 70% with no difference between arms; PFS was higher with CHOP-RIT vs R-CHOP (47% vs 34%); estimated cure rate 42%.
Secondary analysisn = 531
Shadman et al. Treatment of Follicular Lymphoma With CHOP and Anti-CD20 Therapy: 15-Year Follow-Up of the SWOG S0016 Trial